SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-24-026664
Filing Date
2024-08-14
Accepted
2024-08-14 12:19:49
Documents
16
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A cont20240813_8ka.htm   iXBRL 8-K/A 32131
2 EXHIBIT 99.1 ex_714475.htm EX-99.1 128802
7 image1.jpg GRAPHIC 3092
  Complete submission text file 0001437749-24-026664.txt   318694

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA noticker-20240813.xsd EX-101.SCH 3441
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20240813_def.xml EX-101.DEF 12184
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20240813_lab.xml EX-101.LAB 16359
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20240813_pre.xml EX-101.PRE 12454
18 EXTRACTED XBRL INSTANCE DOCUMENT cont20240813_8ka_htm.xml XML 3096
Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

IRS No.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-42001 | Film No.: 241205753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)